EB-2 National Interest Waiver

EB‑2 NIW Approval for a Medical Biochemist

Applicant Profile

Applicant
Medical biochemist and biomedical researcher
Academic background
Ph.D. in Medical Biochemistry
Research experience
Esophageal research and U.S. postdoctoral research
Research focus
Reflux disease, pepsin, esophageal inflammation, and epithelial barrier function
Proposed endeavor
Biomarker validation, disease-mechanism research, and evaluation of pepsin-targeted therapies
Petition category
EB-2 National Interest Waiver
Outcome
Approved without a Request for Evidence
Redacted USCIS approval notice for a medical biochemist’s EB-2 NIW petitionClick to view
EB-2 NIW Approval Notice
A medical biochemist secured NIW approval with a research plan connecting pepsin biomarkers, reflux-related tissue injury, and targeted therapeutic investigation.

Approval Story

Celiksoy Law secured EB-2 National Interest Waiver approval for a medical biochemist whose research examines how reflux damages the esophagus and how pepsin may contribute to that injury. Her petition connected a sustained research background with a defined U.S. endeavor: investigating pepsin as a biomarker, studying pathways associated with tissue damage and disease progression, and evaluating therapies designed to limit pepsin-mediated injury.

USCIS approved the petition without issuing a Request for Evidence. The case brought together research publications, funded work, professional recognition, and expert assessments to explain both the proposed contribution and the applicant’s preparation to pursue it.

A research career focused on reflux-related injury

Our client’s training combined biology with graduate study in medical biochemistry. Her doctoral research examined reflux disease through patient-derived tissue, inflammatory responses, and the proteins that help maintain the esophageal lining. Her subsequent research experience included a postdoctoral appointment in the United States, where she extended this work to pepsin and potential approaches to limiting its effects.

Pepsin is a digestive enzyme investigated in this research as a contributor to reflux-related injury. The client’s work linked questions about its measurement with questions about the cellular changes it may trigger. That connection gave the petition a coherent scientific direction: understanding an injury mechanism could help guide both diagnostic research and the evaluation of therapeutic candidates.

Her background also included laboratory teaching and student mentoring. These activities supported the account of her research capabilities, particularly her experience explaining methods, guiding experimental work, and helping others interpret scientific findings.

The proposed U.S. endeavor

The proposed endeavor addressed three connected research objectives.

The first was to investigate and validate pepsin as a diagnostic or prognostic biomarker in gastroesophageal reflux disease, laryngopharyngeal reflux, and reflux-related pulmonary aspiration. This included further work on measurement methods, reference values, and the interpretation of results across different patient groups.

The second was to examine molecular and inflammatory pathways involved in tissue injury and disease progression. The proposed work linked tissue analysis with gene-expression studies to investigate changes relevant to the esophageal barrier and the progression from Barrett’s esophagus toward esophageal adenocarcinoma.

The third was to evaluate pepsin-targeted therapeutic approaches in experimental models. The plan included investigating amprenavir in normal and Barrett’s esophageal cells, including models using patient-derived gastric juice. These experiments were intended to generate evidence about mechanisms and potential protective effects before conclusions about clinical use could be drawn.

The petition explained the broader relevance of this program through its potential to inform diagnostic methods and treatment development. It also connected those objectives to the client’s existing experience with tissue samples, cell models, inflammatory markers, and transcriptomic analysis.

Publications connected the plan to practical research experience

Several areas of her published work helped explain why the proposed endeavor followed naturally from her previous research.

Pepsin measurement and reflux phenotypes. A study she coauthored as first author examined gastric pepsin and pH across reflux-related patient groups and controls. More severe erosive disease showed the highest pepsin levels and lowest pH, while nonerosive reflux disease showed the opposite pattern among the patient groups. This supported her experience investigating biological differences within reflux presentations; it did not establish a validated test for every reflux condition.

Inflammation and esophageal barrier function. Her research included cytokine measurements and inflammatory gene-expression analysis in patient biopsies. Another study examined the esophageal barrier before and after anti-reflux surgery, assessing permeability, electrical resistance, and junction-related proteins. Together, these studies supported the link between her biochemical methods and questions arising from patient-derived tissue.

Protection against pepsin-related cellular changes. In vitro research examined sodium alginate formulations in an esophageal cell model exposed to weakly acidic pepsin. Transcriptomic analysis helped assess changes in pathways associated with injury and inflammation. A separate study investigated amprenavir in normal and precancerous esophageal cell models and its effects on pepsin-induced gene-expression changes. These were laboratory investigations of potential protective mechanisms.

Disease progression and epigenetics. Her coauthored review of epigenetic changes in Barrett’s esophagus and esophageal adenocarcinoma contributed a literature-based perspective on disease progression. It complemented the experimental work without being presented as an original clinical trial or a validated cancer-prediction tool.

The evidence and its role in the petition

Evidence described in the petitionRole in the presentation
Medical biochemistry degrees and research appointmentsEstablished advanced training and experience relevant to the proposed methods.
First-author research publicationsConnected the applicant’s work to pepsin measurement, inflammatory pathways, tissue integrity, and experimental therapeutic evaluation.
Epigenetics reviewShowed engagement with the literature on Barrett’s esophagus and cancer-related progression.
Early-career investigator award with project fundingSupported recognition of a pepsin-focused research proposal and her role as principal investigator.
Participation in other funded projectsDemonstrated collaborative research experience, with co-investigator and funded-scholar roles distinguished from project leadership.
Publication citations and expert lettersHelped explain the reception, context, and relevance of her work; letters included both independent experts and professional collaborators.
Journal peer review and research award judgingDocumented separate activities evaluating other researchers’ work.
Invited presentations and conference contributionsShowed dissemination of research and participation in scientific exchange.
Laboratory teaching and mentoringSupported experience guiding research methods and developing scientific skills.
Proposed research plan and U.S. research backgroundLinked future objectives to methods, collaborations, and experience described in the petition.

The evidence served different purposes. An award supporting a defined project helped explain research recognition and resources. Participation in a team-funded study explained collaborative experience. Expert letters provided professional context for particular contributions. Presenting these distinctions made the relationship between the record and the proposed endeavor clearer.

A petition built around a connected research program

We organized the petition around the relationship between the client’s completed work and the research she proposed to pursue. Biomarker investigation, tissue-injury mechanisms, and therapeutic evaluation were presented as connected parts of a research program.

We also reviewed evidence beyond the publication list, including funded activities, peer review, presentations, mentoring, and professional assessments. During preparation, we developed the petition and assisted with reference-letter drafts. The client reviewed the scientific descriptions and provided feedback, helping us explain technical work clearly while preserving its meaning.

This approach allowed us to describe the applicant’s contribution within collaborative research and to distinguish established findings from future objectives. The petition argued for the significance of the proposed endeavor and the client’s ability to advance it; the approval notice did not provide a detailed explanation of USCIS’s assessment of each item.

EB-2 NIW approval without an RFE

USCIS approved the EB-2 NIW petition without requesting additional evidence. The case illustrates how a focused biomedical research record can be presented through the connection between prior methods, documented contributions, and a specific future research plan.

At Celiksoy Immigration Lawyers, we assess researchers’ qualifications, proposed U.S. endeavors, and supporting records together. To discuss an EB-2 NIW petition, contact us at us@celiksoylaw.com. Each case is assessed on its own facts and evidence.

Free EB-2 NIW Assessment

Could You Qualify for EB-2 NIW?

Upload your resume so we can review your background in more detail. PDF or Word, up to 5 MB.

Each petition is assessed on its own facts and the evidence submitted. The results shared here do not guarantee that another petition will have the same outcome.

All Approvals

Planning a Similar Petition?

Every case is unique. Based on your education, professional experience or investment plans, we can assess the immigration route that suits you. Book a consultation or complete the assessment form to tell us about your situation and goals.